Oxford BioMedica
Oxford BioMedica
Medawar Centre
Robert Robinson Avenue
Oxford
OX4 4GA
Medawar Centre
Robert Robinson Avenue
Oxford
OX4 4GA
Latest Articles
Agreement to commercialise Trovax for cancer
Oxford BioMedica | Added: 28 Mar 2007
Oxford BioMedica and Sanofi-Aventis have entered into an exclusive global licensing agreement to de…
Oxford Biomedica to acquire Oxxon Therapeutics
Oxford BioMedica | Added: 12 Mar 2007
Acquisition of privately held biotechnology company, based in Oxford, UK, adds melanoma cancer vacc…
TroVax trial adopted by UK clinical trial network
Oxford BioMedica | Added: 10 Jan 2007
Oxford BioMedica reports that the Phase III Trist trial of its novel cancer immunotherapy, TroVax, …
Expanded licencing agreement for Lentivector
Oxford BioMedica | Added: 19 Dec 2006
Oxford BioMedica has expanded an existing licence agreement for its LentiVector technology with a m…
EU orphan drug designation for Trovax
Oxford BioMedica | Added: 8 Dec 2006
Oxford BioMedica's Trovax receives positive recommendation for orphan drug designation in renal can…
